Optimization of the purification process and characterization of natural variants and truncated forms of enterocin L50A/L50B from <i>Enterococcus durans</i> LC2 with antibacterial activity
Structurally modified enterocins C1 and C2 show promising synergistic activity against MDR pathogens, highlighting their potential as alternative therapeutic agents in the fight against antimicrobial resistance.
Authors
- Saïd Ennahar (ORCID: https://orcid.org/0000-0001-8987-7703)
- Kamar Amensag
- Rajaê Belkhou
- Mohammed Ilyass Zaikoumi (ORCID: https://orcid.org/0009-0003-5754-2943)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Laboratoire de Chémo-biologie synthétique et thérapeutique (FR)
- Sidi Mohamed Ben Abdellah University (MA)
Publication Details
- Journal
- Journal of Applied Microbiology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1093/jambio/lxaf283
- Primary Topic
- Probiotics and Fermented Foods
- Type
- article
- Field-Weighted Citation Impact
- 0.00